BioVeris (BIOV) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : BioVeris (BIOV)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: Paul Lee	8/8/2006 1:41:01 PM
	of 40

NOTICE OF INTENT TO AWARD A SOLE SOURCE CONTRACT TO BIOVERIS CORPORATION TO PROVIDE ANTHAX SPORE TEST KITS TO OPERATE THE M8 ASSAY DEVELOPMENT WORKSTATION AND PERFORM REQUIRED ANALYSIS. (SNOTE) SOL USA-SNOTE-060807-002 NAICS: 334511 BioVeris Corporation develops and markets biological detection systems based on its proprietary electrochemiluminescent echnology (BioVeris tm(BVtm) detection technology), which provies a unique combination of sensitivity, reliability, speed, and fle xibility. BioVeris incorporates its BVtm detection technology into its instrument systems, tests, and reagents, which are the biological and chemical components used to perform such tests. BiVeris Corporations's worldwide patent portfolio bradly covers t he use of BV technology in diagnostic and other biological applications. this notice of intent is not a request for competitive proposals or a solicitation of offers. The point of contact for this action is Irene Mancuso, Contract specialist, 410-278-1941, irene.mancuso@us.army.mil. CITE: www2.fbo.gov. Posted 08/07/06 (fbodaily.com W-SN01108221). (0219)

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next